Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases (NDs) are currently incurable diseases that cause progressive degeneration of nerve cells. Many of the disease-causing proteins of NDs are “undruggable” for traditional small-molecule inhibitors (SMIs). None of the compounds that attenuated the amyloid-β (Aβ) accumulation process have entered clinical practice, and many phase III clinical trials of SMIs for Alzheimer’s disease (AD) have failed. In recent years, emerging targeted protein degradation (TPD) technologies such as proteolysis-targeting chimeras (PROTACs), lysosome-targeting chimaeras (LYTACs), and autophagy-targeting chimeras (AUTACs) with TPD-assistive technologies such as click-formed proteolysis-targeting chimeras (CLIPTACs) and deubiquitinase-targeting chimera (DUBTAC) have developed rapidly. In vitro and in vivo experiments have also confirmed that TPD technology can target the degradation of ND pathogenic proteins, bringing hope for the treatment of NDs. Herein, we review the latest TPD technologies, introduce their targets and technical characteristics, and discuss the emerging TPD technologies with potential in ND research, with the hope of providing a new perspective for the development of TPD technology in the NDs field.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These PROTACs target tau protein, phosphokinase GSK-3β, HDACs, BET proteins, and transthyretin (TTR)-Aβ interaction, exhibiting characteristics such as low dosage requirements, high efficacy, and high target selectivity.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [575]
In the citing paper
“The PROTACs exploit the UPS system to precisely target specific proteins, improving the accuracy and speed of protein degradation.575”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [575]
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
MTOR: a pharmacologic target for autophagy regulation
Kim, Y. C., & Guan, K.-L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73939 · Cited by 2,126
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Lysosome-targeting chimaeras for degradation of extracellular proteins
Banik, S. M., Pedram, K., Wisnovsky, S., Ahn, G., Riley, N. M., & Bertozzi, C. R. (2020) · Nature · doi:10.1038/s41586-020-2545-9 · Cited by 1,199
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
The dTAG system for immediate and target-specific protein degradation
Nabet, B., Roberts, J. M., Buckley, D. L., Paulk, J., Dastjerdi, S., Yang, A., Leggett, A. L., Erb, M. A., Lawlor, M. A., Souza, A., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0021-8 · Cited by 1,118
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
Ravikumar, B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1107 · Cited by 1,111
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
Targeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
The ubiquitin-proteasome system
Nandi, D., Tahiliani, P., Kumar, A., & Chandu, D. (2006) · Journal of Biosciences · doi:10.1007/bf02705243 · Cited by 758
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Takahashi, D., Moriyama, J., Nakamura, T., Miki, E., Takahashi, E., Sato, A., Akaike, T., Itto-Nakama, K., & Arimoto, H. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.009 · Cited by 675
Schneekloth, A. R., Pucheault, M., Tae, H. S., & Crews, C. M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.114 · Cited by 635
Advancing targeted protein degradation for cancer therapy
Dale, B., Cheng, M., Park, K.-S., Kaniskan, H. Ü., Xiong, Y., & Jin, J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00365-x · Cited by 632
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
Ahn, G., Banik, S. M., Miller, C. L., Riley, N. M., Cochran, J. R., & Bertozzi, C. R. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00770-1 · Cited by 619
Plasticity in binding confers selectivity in ligand-induced protein degradation
Nowak, R. P., DeAngelo, S. L., Buckley, D., He, Z., Donovan, K. A., An, J., Safaee, N., Jedrychowski, M. P., Ponthier, C. M., Ishoey, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0055-y · Cited by 615
Allele-selective lowering of mutant HTT protein by HTT–LC3 linker compounds
Li, Z., Wang, C., Wang, Z., Zhu, C., Li, J., Sha, T., Ma, L., Gao, C., Yang, Y., Sun, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1722-1 · Cited by 551
Self-citationHaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins
Buckley, D. L., Raina, K., Darricarrere, N., Hines, J., Gustafson, J. L., Smith, I. E., Miah, A. H., Harling, J. D., & Crews, C. M. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00442 · Cited by 488
Chemical Genetic Control of Protein Levels: Selective in Vivo Targeted Degradation
Schneekloth, J. S., Fonseca, F. N., Koldobskiy, M., Mandal, A., Deshaies, R., Sakamoto, K., & Crews, C. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039025z · Cited by 487
Kabat, M., Bobkov, I., Kumar, S., & Grumet, M. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0202 · Cited by 444
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 437
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Deng, X., Dzamko, N., Prescott, A., Davies, P., Liu, Q., Yang, Q., Lee, J.-D., Patricelli, M. P., Nomanbhoy, T. K., Alessi, D. R., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.538 · Cited by 417
Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
Lebraud, H., Wright, D. J., Johnson, C. N., & Heightman, T. D. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00280 · Cited by 413
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Ishida, T., & Ciulli, A. (2021) · SLAS Discovery · doi:10.1177/2472555220965528 · Cited by 380
Light-Induced Protein Degradation with Photocaged PROTACs
Xue, G., Wang, K., Zhou, D., Zhong, H., & Pan, Z. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b06422 · Cited by 377
Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery
Dong, G., Ding, Y., He, S., & Sheng, C. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00895 · Cited by 369
Selective autophagy as a potential therapeutic target for neurodegenerative disorders
Scrivo, A., Bourdenx, M., Pampliega, O., & Cuervo, A. M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30238-2 · Cited by 355
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
Fuji, R. N., Flagella, M., Baca, M., S. Baptista, M. A., Brodbeck, J., Chan, B. K., Fiske, B. K., Honigberg, L., Jubb, A. M., Katavolos, P., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3634 · Cited by 352
Deubiquitinase-targeting chimeras for targeted protein stabilization
Henning, N. J., Boike, L., Spradlin, J. N., Ward, C. C., Liu, G., Zhang, E., Belcher, B. P., Brittain, S. M., Hesse, M. J., Dovala, D., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-00971-2 · Cited by 344
Old Drugs as New Treatments for Neurodegenerative Diseases
Durães, F., Pinto, M., & Sousa, E. (2018) · Pharmaceuticals · doi:10.3390/ph11020044 · Cited by 343
Endolysosomal proteolysis and its regulation
Pillay, C. S., Elliott, E., & Dennison, C. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630417 · Cited by 342
PHOTACs enable optical control of protein degradation
Reynders, M., Matsuura, B. S., Bérouti, M., Simoneschi, D., Marzio, A., Pagano, M., & Trauner, D. (2020) · Science Advances · doi:10.1126/sciadv.aay5064 · Cited by 321
Lu, M., Liu, T., Jiao, Q., Ji, J., Tao, M., Liu, Y., You, Q., & Jiang, Z. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.063 · Cited by 310
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases
Neef, D. W., Jaeger, A. M., & Thiele, D. J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3453 · Cited by 307
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
Silva, M. C., Ferguson, F. M., Cai, Q., Donovan, K. A., Nandi, G., Patnaik, D., Zhang, T., Huang, H.-T., Lucente, D. E., Dickerson, B. C., et al. (2019) · eLife · doi:10.7554/elife.45457 · Cited by 283
Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein
Bauer, P. O., Goswami, A., Wong, H. K., Okuno, M., Kurosawa, M., Yamada, M., Miyazaki, H., Matsumoto, G., Kino, Y., Nagai, Y., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1608 · Cited by 280
Cullin-RING Ligases as Attractive Anti-cancer Targets
Zhao, Y., & Sun, Y. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990300 · Cited by 278
Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation
Chu, T.-T., Gao, N., Li, Q.-Q., Chen, P.-G., Yang, X.-F., Chen, Y.-X., Zhao, Y.-F., & Li, Y.-M. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.02.016 · Cited by 247
Maniaci, C., Hughes, S. J., Testa, A., Chen, W., Lamont, D. J., Rocha, S., Alessi, D. R., Romeo, R., & Ciulli, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00954-1 · Cited by 245
Wang, W., Zhou, Q., Jiang, T., Li, S., Ye, J., Zheng, J., Wang, X., Liu, Y., Deng, M., Ke, D., et al. (2021) · Theranostics · doi:10.7150/thno.55680 · Cited by 242
Self-citationde Wispelaere, M., Du, G., Donovan, K. A., Zhang, T., Eleuteri, N. A., Yuan, J. C., Kalabathula, J., Nowak, R. P., Fischer, E. S., Gray, N. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11429-w · Cited by 237
Targeting autophagy in disease: established and new strategies
Kocak, M., Ezazi Erdi, S., Jorba, G., Maestro, I., Farrés, J., Kirkin, V., Martinez, A., & Pless, O. (2022) · Autophagy · doi:10.1080/15548627.2021.1936359 · Cited by 228
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
Simonetta, K. R., Taygerly, J., Boyle, K., Basham, S. E., Padovani, C., Lou, Y., Cummins, T. J., Yung, S. L., von Soly, S. K., Kayser, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09358-9 · Cited by 217
Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation
Fan, X., Jin, W. Y., Lu, J., Wang, J., & Wang, Y. T. (2014) · Nature Neuroscience · doi:10.1038/nn.3637 · Cited by 214
Self-citationSmall Molecule Targeted Recruitment of a Nuclease to RNA
Costales, M. G., Matsumoto, Y., Velagapudi, S. P., & Disney, M. D. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01233 · Cited by 212
ATTEC: a potential new approach to target proteinopathies
Li, Z., Zhu, C., Ding, Y., Fei, Y., & Lu, B. (2020) · Autophagy · doi:10.1080/15548627.2019.1688556 · Cited by 206
Haniff, H. S., Tong, Y., Liu, X., Chen, J. L., Suresh, B. M., Andrews, R. J., Peterson, J. M., O’Leary, C. A., Benhamou, R. I., Moss, W. N., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00984 · Cited by 205
Emerging New Concepts of Degrader Technologies
Ding, Y., Fei, Y., & Lu, B. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.005 · Cited by 204
LIU, C.-G., SONG, J., ZHANG, Y.-Q., & WANG, P.-C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2484 · Cited by 201
Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation
McEwan, W. A., Falcon, B., Vaysburd, M., Clift, D., Oblak, A. L., Ghetti, B., Goedert, M., & James, L. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607215114 · Cited by 201
Stem cell-based regenerative medicine
Rajabzadeh, N., Fathi, E., & Farahzadi, R. (2019) · Stem Cell Investigation · doi:10.21037/sci.2019.06.04 · Cited by 200
PROTACs: A novel strategy for cancer therapy
Liu, J., Ma, J., Liu, Y., Xia, J., Li, Y., Wang, Z. P., & Wei, W. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.006 · Cited by 186
Costales, M. G., Aikawa, H., Li, Y., Childs-Disney, J. L., Abegg, D., Hoch, D. G., Pradeep Velagapudi, S., Nakai, Y., Khan, T., Wang, K. W., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914286117 · Cited by 185
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras
Samarasinghe, K. T. G., Jaime-Figueroa, S., Burgess, M., Nalawansha, D. A., Dai, K., Hu, Z., Bebenek, A., Holley, S. A., & Crews, C. M. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.03.011 · Cited by 182
Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
Van Bulck, M., Sierra-Magro, A., Alarcon-Gil, J., Perez-Castillo, A., & Morales-Garcia, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030719 · Cited by 178
Constitutive Upregulation of Chaperone-Mediated Autophagy in Huntington's Disease
Koga, H., Martinez-Vicente, M., Arias, E., Kaushik, S., Sulzer, D., & Cuervo, A. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3219-11.2011 · Cited by 174
Acute and rapid degradation of endogenous proteins by Trim-Away
Clift, D., So, C., McEwan, W. A., James, L. C., & Schuh, M. (2018) · Nature Protocols · doi:10.1038/s41596-018-0028-3 · Cited by 174
Hines, J., Gough, J. D., Corson, T. W., & Crews, C. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217206110 · Cited by 172
Béraud, D., Hathaway, H. A., Trecki, J., Chasovskikh, S., Johnson, D. A., Johnson, J. A., Federoff, H. J., Shimoji, M., Mhyre, T. R., & Maguire-Zeiss, K. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9401-0 · Cited by 172
Xu, X., Sun, Y., Cen, X., Shan, B., Zhao, Q., Xie, T., Wang, Z., Hou, T., Xue, Y., Zhang, M., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00858-3 · Cited by 171
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Liu, Y., Liang, C., Xin, L., Ren, X., Tian, L., Ju, X., Li, H., Wang, Y., Zhao, Q., Liu, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112711 · Cited by 170
Self-citationZhang, K., Zhu, S., Li, J., Jiang, T., Feng, L., Pei, J., Wang, G., Ouyang, L., & Liu, B. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.016 · Cited by 169
The potential role of neuroinflammation and transcription factors in Parkinson disease
Tiwari, P. C., & Pal, R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.1/rpal · Cited by 164
How We Think about Targeting RNA with Small Molecules
Costales, M. G., Childs-Disney, J. L., Haniff, H. S., & Disney, M. D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01927 · Cited by 164
SNIPERs—Hijacking IAP activity to induce protein degradation
Naito, M., Ohoka, N., & Shibata, N. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2018.12.002 · Cited by 162
Kumar, V., Xin, X., Ma, J., Tan, C., Osna, N., & Mahato, R. I. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113888 · Cited by 160
14-3-3 Proteins Are on the Crossroads of Cancer, Aging, and Age-Related Neurodegenerative Disease
Fan, X., Cui, L., Zeng, Y. Y., Song, W., Gaur, U., & Yang, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143518 · Cited by 156
Homo-PROTACs for the Chemical Knockdown of Cereblon
Steinebach, C., Lindner, S., Udeshi, N. D., Mani, D. C., Kehm, H., Köpff, S., Carr, S. A., Gütschow, M., & Krönke, J. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00693 · Cited by 155
Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC
Boike, L., Cioffi, A. G., Majewski, F. C., Co, J., Henning, N. J., Jones, M. D., Liu, G., McKenna, J. M., Tallarico, J. A., Schirle, M., et al. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.09.001 · Cited by 154
Biological and clinical manifestations of juvenile Huntington’s disease: A retrospective analysis
Fusilli, C., Migliore, S., Mazza, T., Consoli, F., De Luca, A., Barbagallo, G., Ciammola, A., Gatto, E. M., Cesarini, M., Etcheverry, J. L., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30294-1 · Cited by 148
First targeted protein degrader hits the clinic
Mullard, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00043-6 · Cited by 146
Discovery of Small Molecules that Induce the Degradation of Huntingtin
Tomoshige, S., Nomura, S., Ohgane, K., Hashimoto, Y., & Ishikawa, M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706529 · Cited by 144
Inhibitor Mediated Protein Degradation
Long, M. J. C., Gollapalli, D. R., & Hedstrom, L. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.04.008 · Cited by 133
Endogenous Nitrated Nucleotide Is a Key Mediator of Autophagy and Innate Defense against Bacteria
Ito, C., Saito, Y., Nozawa, T., Fujii, S., Sawa, T., Inoue, H., Matsunaga, T., Khan, S., Akashi, S., Hashimoto, R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.024 · Cited by 126
Zhou, J., Chong, S. Y., Lim, A., Singh, B. K., Sinha, R. A., Salmon, A. B., & Yen, P. M. (2017) · Aging · doi:10.18632/aging.101181 · Cited by 126
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
Owens, W. A., Walaszczyk, A., Spyridopoulos, I., Dookun, E., & Richardson, G. D. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111540 · Cited by 122
Tanaka, S., Ishii, A., Ohtaki, H., Shioda, S., Yoshida, T., & Numazawa, S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-143 · Cited by 118
Amyloid-β Induces Smac Release via AP-1/Bim Activation in Cerebral Endothelial Cells
Yin, K. J., Lee, J.-M., Chen, S. D., Xu, J., & Hsu, C. Y. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09764.2002 · Cited by 117
Toyo-oka, K., Wachi, T., Hunt, R. F., Baraban, S. C., Taya, S., Ramshaw, H., Kaibuchi, K., Schwarz, Q. P., Lopez, A. F., & Wynshaw-Boris, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2513-13.2014 · Cited by 115
Strategies for designing proteolysis targeting chimaeras (PROTACs)
He, S., Dong, G., Cheng, J., Wu, Y., & Sheng, C. (2022) · Medicinal Research Reviews · doi:10.1002/med.21877 · Cited by 108
Target-induced clustering activates Trim-Away of pathogens and proteins
Zeng, J., Santos, A. F., Mukadam, A. S., Osswald, M., Jacques, D. A., Dickson, C. F., McLaughlin, S. H., Johnson, C. M., Kiss, L., Luptak, J., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00560-2 · Cited by 106
DYRK1A inhibitors for disease therapy: Current status and perspectives
Liu, T., Wang, Y., Wang, J., Ren, C., Chen, H., & Zhang, J. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114062 · Cited by 105
Self-citationThe ubiquitin–proteasome system and its potential application in hepatocellular carcinoma therapy
Chen, Y., Wu, H., & Shen, X. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.023 · Cited by 104
Small-Molecule Stabilization of 14-3-3 Protein-Protein Interactions Stimulates Axon Regeneration
Kaplan, A., Morquette, B., Kroner, A., Leong, S. Y., Madwar, C., Sanz, R., Banerjee, S. L., Antel, J. P., Bisson, N., David, S., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.018 · Cited by 96
Targeting selective autophagy by AUTAC degraders
Takahashi, D., & Arimoto, H. (2020) · Autophagy · doi:10.1080/15548627.2020.1718362 · Cited by 95
Rai, S. N., Tiwari, N., Singh, P., Mishra, D., Singh, A. K., Hooshmandi, E., Vamanu, E., & Singh, M. P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.777347 · Cited by 95
Ahn, G., Banik, S. M., & Bertozzi, C. R. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.02.024 · Cited by 93
L'Episcopo, F., Drouin-Ouellet, J., Tirolo, C., Pulvirenti, A., Giugno, R., Testa, N., Caniglia, S., Serapide, M. F., Cisbani, G., Barker, R. A., et al. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.104 · Cited by 92
Qu, J., Ren, X., Xue, F., He, Y., Zhang, R., Zheng, Y., Huang, H., Wang, W., & Zhang, J. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.03.010 · Cited by 91
Self-citationIndomethacin-based PROTACs as pan-coronavirus antiviral agents
Desantis, J., Mercorelli, B., Celegato, M., Croci, F., Bazzacco, A., Baroni, M., Siragusa, L., Cruciani, G., Loregian, A., & Goracci, L. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113814 · Cited by 91
Molecular Strategies to Target Protein Aggregation in Huntington’s Disease
Jarosińska, O. D., & Rüdiger, S. G. D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.769184 · Cited by 90
Squitieri, F., Frati, L., Ciarmiello, A., Lastoria, S., & Quarrell, O. W. J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.012 · Cited by 88
The proteasome and its role in the nervous system
Türker, F., Cook, E. K., & Margolis, S. S. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.04.003 · Cited by 88
Protein degradation technology: a strategic paradigm shift in drug discovery
Li, H., Dong, J., Cai, M., Xu, Z., Cheng, X.-D., & Qin, J.-J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01146-7 · Cited by 88
Kargbo, R. B. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00192 · Cited by 87
Cao, F., de Weerd, S., Chen, D., Zwinderman, M. R. H., van der Wouden, P. E., & Dekker, F. J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112800 · Cited by 86
Cuadrado, A. (2022) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-103416 · Cited by 86
Tomoshige, S., & Ishikawa, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202004746 · Cited by 82
RIBOTACs: Small Molecules Target RNA for Degradation
Dey, S. K., & Jaffrey, S. R. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.07.015 · Cited by 81
14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases
Pair, F. S., & Yacoubian, T. A. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.001 · Cited by 78
Treatment of Alzheimer’s by PROTAC-Tau Protein Degradation
Kargbo, R. B. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00083 · Cited by 77
Bush, J. A., Aikawa, H., Fuerst, R., Li, Y., Ursu, A., Meyer, S. M., Benhamou, R. I., Chen, J. L., Khan, T., Wagner-Griffin, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5991 · Cited by 77
VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives
Wang, C., Zhang, Y., Wang, J., & Xing, D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113906 · Cited by 76
Self-citationSelective Autophagy Receptors in Neuronal Health and Disease
Conway, O., Akpinar, H. A., Rogov, V. V., & Kirkin, V. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.013 · Cited by 75
Lobbestael, E., Civiero, L., De Wit, T., Taymans, J.-M., Greggio, E., & Baekelandt, V. (2016) · Scientific Reports · doi:10.1038/srep33897 · Cited by 71
α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator
Zhu, Y., Duan, C., Li, L., Gao, H., Zhao, C., Yu, S., Uéda, K., Chan, P., & Yang, H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.014 · Cited by 70
LRRK2 dephosphorylation increases its ubiquitination
Zhao, J., Molitor, T. P., Langston, J. W., & Nichols, R. J. (2015) · Biochemical Journal · doi:10.1042/bj20141305 · Cited by 69
Monomeric Targeted Protein Degraders
Hanan, E. J., Liang, J., Wang, X., Blake, R. A., Blaquiere, N., & Staben, S. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00093 · Cited by 69
Ciccone, L., Shi, C., di Lorenzo, D., Van Baelen, A.-C., & Tonali, N. (2020) · Molecules · doi:10.3390/molecules25102439 · Cited by 69
Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy
Ma, Z., Yu, J. H., Yu, Y., & Liang, D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113247 · Cited by 65
Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease
Wilson, B., & Geetha, K. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.044 · Cited by 64
Jeong, J.-J., Woo, J.-Y., Kim, K.-A., Han, M. J., & Kim, D.-H. (2015) · Letters in Applied Microbiology · doi:10.1111/lam.12393 · Cited by 63
Hydrophobic tagging-mediated degradation of Alzheimer's disease related Tau
Gao, N., Chu, T.-T., Li, Q.-Q., Lim, Y.-J., Qiu, T., Ma, M.-R., Hu, Z.-W., Yang, X.-F., Chen, Y.-X., Zhao, Y.-F., et al. (2017) · RSC Advances · doi:10.1039/c7ra05347a · Cited by 62
PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases
Jiang, X., Zhou, J., Wang, Y., Liu, X., Xu, K., Xu, J., Feng, F., & Sun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112949 · Cited by 62
Self-citationTransforming targeted cancer therapy with PROTACs: A forward-looking perspective
Farnaby, W., Koegl, M., McConnell, D. B., & Ciulli, A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.02.009 · Cited by 62
Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases
Hyun, S., & Shin, D. (2021) · Life · doi:10.3390/life11070607 · Cited by 60
Tomoshige, S., Nomura, S., Ohgane, K., Hashimoto, Y., & Ishikawa, M. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.012 · Cited by 59
Reversible Covalent Imine-Tethering for Selective Stabilization of 14-3-3 Hub Protein Interactions
Cossar, P. J., Wolter, M., Dijck, L. V., Valenti, D., Levy, L. M., Ottmann, C., & Brunsveld, L. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03035 · Cited by 59
Senotherapeutics: Targeting senescent cells for the main age-related diseases
Boccardi, V., & Mecocci, P. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111526 · Cited by 58
Transcription factor EB: an emerging drug target for neurodegenerative disorders
Song, J.-X., Liu, J., Jiang, Y., Wang, Z.-Y., & Li, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.013 · Cited by 56
TDP-43 specific reduction induced by Di-hydrophobic tags conjugated peptides
Gao, N., Huang, Y., Chu, T., Li, Q., Zhou, B. N., Chen, Y., Zhao, Y., & Li, Y. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.042 · Cited by 55
Hirai, K., Yamashita, H., Tomoshige, S., Mishima, Y., Niwa, T., Ohgane, K., Ishii, M., Kanamitsu, K., Ikemi, Y., Nakagawa, S., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00500 · Cited by 55
Ohoka, N., Ujikawa, O., Shimokawa, K., Sameshima, T., Shibata, N., Hattori, T., Nara, H., Cho, N., & Naito, M. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c18-00567 · Cited by 54
Geiger, T. M., Schäfer, S. C., Dreizler, J. K., Walz, M., & Hausch, F. (2022) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2021.100018 · Cited by 52
Ceyzériat, K., Zilli, T., Millet, P., Frisoni, G. B., Garibotto, V., & Tournier, B. B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200304085513 · Cited by 51
Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration
Sul, J.-W., Park, M., Shin, J., Kim, Y., Yoo, S., Kong, Y., Kwon, K., Lee, Y., & Kim, E. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt006 · Cited by 49
Targeting methionine aminopeptidase 2 in cancer, obesity, and autoimmunity
Grocin, A. G., Kallemeijn, W. W., & Tate, E. W. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.07.004 · Cited by 49
Araldi, R. P., D’Amelio, F., Vigerelli, H., de Melo, T. C., & Kerkis, I. (2020) · Cells · doi:10.3390/cells9122663 · Cited by 48
Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
Wang, C., Zhang, Y., Shi, L., Yang, S., Chang, J., Zhong, Y., Li, Q., & Xing, D. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2074414 · Cited by 47
Roles of forkhead box O (FoxO) transcription factors in neurodegenerative diseases: A panoramic view
Hu, W., Yang, Z., Yang, W., Han, M., Xu, B., Yu, Z., Shen, M., & Yang, Y. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101645 · Cited by 43
Grohmann, C., Magtoto, C. M., Walker, J. R., Chua, N. K., Gabrielyan, A., Hall, M., Cobbold, S. A., Mieruszynski, S., Brzozowski, M., Simpson, D. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29670-1 · Cited by 43
Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02472-0 · Cited by 42
Neurodegenerative Disorders Treatment: The MicroRNA Role
Ridolfi, B., & Abdel-Haq, H. (2018) · Current Gene Therapy · doi:10.2174/1566523218666180119120726 · Cited by 41
Pradeepkiran, J. A., & Reddy, P. H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166162 · Cited by 41
Potjewyd, F., & Axtman, A. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.768655 · Cited by 40
Chaperone-mediated autophagy: Advances from bench to bedside
Li, W., Nie, T., Xu, H., Yang, J. H., Yang, Q., & Mao, Z. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.010 · Cited by 38
Shaheer, M., Singh, R., & Sobhia, M. E. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1953601 · Cited by 36
Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer
Yokoo, H., Shibata, N., Naganuma, M., Murakami, Y., Fujii, K., Ito, T., Aritake, K., Naito, M., & Demizu, Y. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00605 · Cited by 35
PROTACs technology for targeting non-oncoproteins: Advances and perspectives
Wang, C., Zhang, Y., Xing, D., & Zhang, R. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105109 · Cited by 34
Targeting lipid droplets for autophagic degradation by ATTEC
Fu, Y., & Lu, B. (2021) · Autophagy · doi:10.1080/15548627.2021.1967616 · Cited by 33
Noh, M., Chun, K., Kang, B. Y., Kim, H., Park, J., Lee, H., Kim, Y. H., Ku, S., & Kim, S. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.065 · Cited by 32
Deubiquitinase-Targeting Chimeras for Targeted Protein StabilizationPreprint
Henning, N. J., Boike, L., Spradlin, J. N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.30.441959 · Cited by 32
Benn, J., Mukadam, A. S., & McEwan, W. A. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.09.012 · Cited by 31
Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease?
Quarrell, O., Nance, M., Nopoulos, P., Reilmann, R., Oosterloo, M., Tabrizi, S. J., Furby, H., Carsten Saft, C., Roos, R. A. C., Squitieri, F., et al. (2019) · Movement Disorders · doi:10.1002/mds.27640 · Cited by 30
Cassidy, K. B., & Zhao, H. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00330 · Cited by 29
Yamashita, H., Tomoshige, S., Nomura, S., Ohgane, K., Hashimoto, Y., & Ishikawa, M. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115175 · Cited by 28
Peptide-Based PROTAC: The Predator of Pathological Proteins
Au, Y. Z., Wang, T., Sigua, L. H., & Qi, J. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.06.002 · Cited by 28
Small‐Molecule‐Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging
Gustafson, J. L., Neklesa, T. K., Cox, C. S., Roth, A. G., Buckley, D. L., Tae, H. S., Sundberg, T. B., Stagg, D. B., Hines, J., McDonnell, D. P., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201503720 · Cited by 28
Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
Schiavone, S., & Trabace, L. (2018) · Molecules · doi:10.3390/molecules23020411 · Cited by 21
Fiorillo, A., Morea, V., Colotti, G., & Ilari, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121309 · Cited by 20
Extracellular protein degradation via the lysosome
Eldeeb, M. A., Zorca, C. E., & Goiran, T. (2020) · Communications Chemistry · doi:10.1038/s42004-020-00397-8 · Cited by 19
Chen, J., Yang, Y., Russu, W. A., & Chan, W. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041654 · Cited by 14
Taming transcription factors with TRAFTACs
Ng, C. S. C., & Banik, S. M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.016 · Cited by 11
Chaperone-mediated autophagy targeting chimeras (CMATAC) for the degradation of ERα in breast cancer
Zhang, J., Huang, Y.-H., LIU, W., Li, L., & Chen, L. (2020) · Biocell · doi:10.32604/biocell.2020.011642 · Cited by 9
Self-citation
Research works printed but not linked: 2
- Citron B. A., 2015, Am. J. Neurodegener. Dis., 4, 40
- Bachstetter A. D., 2010, Aging Dis., 1, 199
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“575 Various reviews 574,575 have consolidated information on PROTACs with potential applications in AD.”
BackgroundSelf-citationProtein degraders enter the clinic — a new approach to cancer therapy
Chirnomas, D., Hornberger, K. R., & Crews, C. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00736-3 · Cited by 658
Proximity-Based Modalities for Biology and Medicine
Liu, X., & Ciulli, A. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00395 · Cited by 196
A bibliometric analysis of PROTAC from 2001 to 2021
Li, D., Yu, D., Li, Y., & Yang, R. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114838 · Cited by 134
Xie, S., Zhu, J., Li, J., Zhan, F., Yao, H., Xu, J., & Xu, S. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00736 · Cited by 117
Metadata
- Authors
- Fang, Y., Wang, J., Zhao, M., Zheng, Q., Ren, C., Wang, Y., & Zhang, J.
- Affiliations
- Sichuan University (CN)
- University of Tennessee Health Science Center (US)
- Chengdu Fifth People's Hospital (CN)
- Corresponding author
- Wang, Yuxi
- Zhang, Jifa
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-08-25
- Volume
- 65
- Issue
- 17
- Pages
- 11454-11477
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W4293102944
- Cited by
- 100
- References
- 163
- Citations by year
- 2026: 16 · 2025: 34 · 2024: 28 · 2023: 20 · 2022: 2
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2018ZX09201018-021)
- Health Commission of Sichuan Province (21PJ149)
- Chinese Academy of Medical Sciences (2020-JKCS-014)
- Natural Science Foundation of Sichuan Province (2022NSFSC1365)
- Department of Science and Technology of Sichuan Province (2019YFS0003)
- National Natural Science Foundation of China (81903502, 82073318)
- Xinglin Foundation of Chengdu University (YYZX2021043)
- West China Hospital, Sichuan University (ZYGD20001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- targeted protein degradation, neurodegenerative diseases, Alzheimer's disease, PROTACs, lysosome-targeting chimeras, undruggable proteins, amyloid-beta, protein degradation
- MeSH terms
- Chimera, Humans, Lysosomes, Proteins, Neurodegenerative Diseases, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.